Global Health (Audio)

There has been a revolution in recent years in the way health is measured, and this revolution promises to change how resources are allocated, how care is delivered, and who benefits from this investment. The panelists discuss new findings on the global burden of disease and what it implies for academic global health researchers, clinical caregivers, policy makers, donors and others. Speakers include George Rutherford, Director, Prevention & Public Health Group, UCSF; Stefano Bertozzi, Dean, School of Public Health, UC Berkeley; Julio Frenk, Dean, School of Public Health, Harvard University; Joy Lawn, Director, MARCH Centre, London School of Hygiene & Tropical Medicine; and Chris Murray, Director, Institute for Health Metrics and Evaluation. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29022]

One of the greatest global health accomplishments of the last 20 years has been the progress in reducing the death rate of children under five years old. However, the death rate among newborns has not declined as quickly, due largely to the rising epidemic of preterm births. The panel discusses new tools and approaches to combat this problem in global and local settings. Speakers include Larry Rand, co-Director, PTBi, Perinatal Director, Fetal Treatment Center and Benioff Endowed Chair in Maternal Fetal Medicine, UCSF; Zulfiqar Bhutta, Founding Director, Center of Excellence in Women and Child Health, The Aga Khan University; Mariam Claeson, Director, Maternal Newborn and Child Health, Bill & Melinda Gates Foundation; Jennifer Howse, President, March of Dimes; and Paul Wise, Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics and Health Policy, Stanford University. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29018]

There has been a revolution in recent years in the way health is measured, and this revolution promises to change how resources are allocated, how care is delivered, and who benefits from this investment. The panelists discuss new findings on the global burden of disease and what it implies for academic global health researchers, clinical caregivers, policy makers, donors and others. Speakers include George Rutherford, Director, Prevention & Public Health Group, UCSF; Stefano Bertozzi, Dean, School of Public Health, UC Berkeley; Julio Frenk, Dean, School of Public Health, Harvard University; Joy Lawn, Director, MARCH Centre, London School of Hygiene & Tropical Medicine; and Chris Murray, Director, Institute for Health Metrics and Evaluation. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29021]

For many years, neglected tropical diseases have been just that: neglected. However a wave of new funding combined with novel tools are generating significant progress against conditions that afflict the most vulnerable populations. Learn about major breakthroughs on the horizon for these tragic diseases. Speakers include Mary Wilson, Visiting Professor, UCSF; Eva Harris, Professor and Director, Center for Global Public Health, UC Berkeley;

Peter Hotez, Founding Dean, National School of Tropical Medicine, Baylor College of Medicine; Mark Rosenberg, President and CEO, The Task Force for Global Health and Roberto Tapia Conyer, Director General, Carlos Slim Foundation. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29017]

Ebola, SARS, MERS, H1N1…. The news cycle highlights just how a rapidly globalizing world can produce threats to health across borders. Experts discuss the latest efforts to prepare for future pandemics and suggest what governments must do to protect their citizens. Speakers include Richard Feachem, Director, Global Health Group, UCSF; Larry Brilliant, President and Senior Adviser to Jeff Skoll, Skoll Global Threats Fund; Dan Kelly, Clinical Fellow, UCSF; and Ramanan Laxminarayan, Vice President, Research and Policy, Public Health Foundation of India. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29015]

Over the last 20 years, international funding flows for health have increased to nearly $30 billion per year. However, funding for global health faces a number of transitions as additional areas seek support and the rising wealth in low-income countries is leading international donors to shift a greater share of the cost to domestic purses. Leading experts discuss the future of global health funding and how it might affect research activities. Speakers include Dean Jamison, Senior Fellow and Health Economist, UCSF; Roger Glass, Director, Fogarty International Center, National Institutes of Health; and Peter Singer, CEO, Grand Challenges Canada. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29020]

No country in human history has reduced mortality rates as quickly as Rwanda in the last 15 years. But are the circumstances that have allowed Rwanda to make this progress unique? Ambassador Eric Goosby moderates a discussion with Paulin Basinga of the Bill & Melinda Gates Foundation and Paul Farmer of Partners in Health about what is replicable from Rwanda and what other countries might learn from its experience. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29023]

Equity is both a goal of global health and a means to achieving greater progress in health. While mortality overall, and especially deaths in children, has fallen rapidly in many low and middle income countries, many inequities within countries have worsened. Future progress in global health will depend on both raising the average standards for health in the least advantaged countries and reducing inequities in health and well-being within all countries. Speakers include Jaime Sepulveda, Sam Hawgood and Harvey Fineberg of UC San Francisco. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29014]

According to the Lancet Commission on Global Surgery, more than 2 billion people worldwide lack access even to basic surgical care. Lack of access to surgery can create permanent incapacities, with an estimated 11-15% of disability in the world due to surgically treatable conditions. Learn what is being done to make essential surgical services available to the world's poorest populations. Speakers include Gavin Yamey, Lead, Evidence to Policy Initiative, UCSF;

Haile Debas, Director, UC Global Health Institute; and

Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine, Harvard University. Series: "The Science of Global Health: What’s Next" [Health and Medicine] [Show ID: 29016]

Despite exciting advances in our awareness and understanding of autism spectrum disorder (ASD), there has been relatively little progress in prevention of this form of neurodevelopmental disorder, or in the development of evidence-based practices to improve outcomes for people with ASD and their families. In addition, most of what is known about the epidemiology, genetics, clinical manifestation and course, treatment, and nearly every other aspect of autism is based on research in high income countries, where fewer than 10% of births occur and less than 20% of the population lives globally. Maureen Durkin, director of the Graduate Program in Population Health at the University of Wisconsin-Madison School of Medicine and Public Health, reviews some of the recent developments in the epidemiology of ASD and describe opportunities to expand the horizons of ASD epidemiolog. Series: "MIND Institute Lecture Series on Neurodevelopmental Disorders" [Health and Medicine] [Professional Medical Education] [Show ID: 28483]